Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -56,385 | -82,667 | -14,859 | 4,134 | -23,982 |
| Depreciation Amortization | 8,121 | 14,217 | 14,487 | 21,382 | 67,066 |
| Income taxes - deferred | 260 | -6,327 | -5,270 | -1,766 | -3,543 |
| Accounts receivable | 3,366 | -1,305 | -5,630 | -6,216 | 5,855 |
| Accounts payable and accrued liabilities | -2,506 | -11 | 1,965 | -1,100 | 822 |
| Other Working Capital | -9,423 | -13,771 | -11,378 | -11,956 | -12,948 |
| Other Operating Activity | 61,970 | 88,076 | 25,094 | 3,919 | -20,205 |
| Operating Cash Flow | $5,403 | $-1,788 | $4,409 | $8,397 | $13,065 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 2,501 | 24,965 |
| PPE Investments | -7,734 | -5,427 | -7,486 | -5,143 | -1,628 |
| Net Acquisitions | -600 | N/A | N/A | -476 | -94,601 |
| Investing Cash Flow | $-8,334 | $-5,427 | $-7,486 | $-3,118 | $-71,264 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 50,000 |
| Debt Repayment | N/A | N/A | -284 | -201 | -50,558 |
| Common Stock Issued | 76 | 23 | 16 | 1,128 | 1,524 |
| Common Stock Repurchased | -10,914 | -5,000 | N/A | N/A | N/A |
| Other Financing Activity | -1,891 | -1,347 | -4,584 | -7,706 | -4,740 |
| Financing Cash Flow | $-12,729 | $-6,324 | $-4,852 | $-6,779 | $-3,774 |
| Exchange Rate Effect | -48 | 79 | -130 | 69 | 327 |
| Beginning Cash Position | 72,867 | 86,327 | 94,386 | 95,817 | 157,463 |
| End Cash Position | 57,159 | 72,867 | 86,327 | 94,386 | 95,817 |
| Net Cash Flow | $-15,708 | $-13,460 | $-8,059 | $-1,431 | $-61,646 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,403 | -1,788 | 4,409 | 8,397 | 13,065 |
| Capital Expenditure | -7,734 | -5,427 | -7,486 | -5,143 | -1,628 |
| Free Cash Flow | -2,331 | -7,215 | -3,077 | 3,254 | 11,437 |